208 related articles for article (PubMed ID: 35600219)
1. Emerging Potential of Plant Virus Nanoparticles (PVNPs) in Anticancer Immunotherapies.
Shahgolzari M; Fiering S
J Cancer Immunol (Wilmington); 2022; 4(1):22-29. PubMed ID: 35600219
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional plant virus nanoparticles in the next generation of cancer immunotherapies.
Shahgolzari M; Dianat-Moghadam H; Fiering S
Semin Cancer Biol; 2022 Nov; 86(Pt 2):1076-1085. PubMed ID: 34375725
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional Plant Virus Nanoparticles for Targeting Breast Cancer Tumors.
Shahgolzari M; Dianat-Moghadam H; Yavari A; Fiering SN; Hefferon K
Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146510
[TBL] [Abstract][Full Text] [Related]
4. Plant Virus Nanoparticles for Vaccine Applications.
Santoni M; Zampieri R; Avesani L
Curr Protein Pept Sci; 2020; 21(4):344-356. PubMed ID: 32048964
[TBL] [Abstract][Full Text] [Related]
5. In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree.
Sheen MR; Fiering S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1524. PubMed ID: 29667346
[TBL] [Abstract][Full Text] [Related]
6. Engaging Pattern Recognition Receptors in Solid Tumors to Generate Systemic Antitumor Immunity.
Brown M
Cancer Treat Res; 2022; 183():91-129. PubMed ID: 35551657
[TBL] [Abstract][Full Text] [Related]
7. Plant Virus Nanoparticles Combat Cancer.
Shahgolzari M; Venkataraman S; Osano A; Akpa PA; Hefferon K
Vaccines (Basel); 2023 Jul; 11(8):. PubMed ID: 37631846
[TBL] [Abstract][Full Text] [Related]
8. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
9. Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy.
Beiss V; Mao C; Fiering SN; Steinmetz NF
Mol Pharm; 2022 May; 19(5):1573-1585. PubMed ID: 35333531
[TBL] [Abstract][Full Text] [Related]
10. Alfalfa mosaic virus nanoparticles-based
Shahgolzari M; Pazhouhandeh M; Milani M; Fiering S; Khosroushahi AY
Nanomedicine (Lond); 2021 Jan; 16(2):97-107. PubMed ID: 33442986
[No Abstract] [Full Text] [Related]
11. In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade.
Mao C; Beiss V; Ho GW; Fields J; Steinmetz NF; Fiering S
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36460333
[TBL] [Abstract][Full Text] [Related]
12. Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-priming.
Aleynick M; Svensson-Arvelund J; Pantsulaia G; Kim K; Rose SA; Upadhyay R; Yellin M; Marsh H; Oreper D; Jhunjhunwala S; Moussion CC; Merad M; Brown BD; Brody JD
J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37487664
[TBL] [Abstract][Full Text] [Related]
13. The Next Generation of Pattern Recognition Receptor Agonists: Improving Response Rates in Cancer Immunotherapy.
O' Donovan DH; Mao Y; Mele DA
Curr Med Chem; 2020; 27(34):5654-5674. PubMed ID: 31250749
[TBL] [Abstract][Full Text] [Related]
14. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
15. Polyethyleneimine-CpG Nanocomplex as an In Situ Vaccine for Boosting Anticancer Immunity in Melanoma.
Xu Y; Ma S; Si X; Zhao J; Yu H; Ma L; Song W; Tang Z
Macromol Biosci; 2021 Feb; 21(2):e2000207. PubMed ID: 33107202
[TBL] [Abstract][Full Text] [Related]
16. Rational Design of T-Cell- and B-Cell-Based Therapeutic Cancer Vaccines.
Li WH; Su JY; Li YM
Acc Chem Res; 2022 Sep; 55(18):2660-2671. PubMed ID: 36048514
[TBL] [Abstract][Full Text] [Related]
17. In vivo cancer vaccination: Which dendritic cells to target and how?
Chiang CL; Kandalaft LE
Cancer Treat Rev; 2018 Dec; 71():88-101. PubMed ID: 30390423
[TBL] [Abstract][Full Text] [Related]
18. Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses.
Vasou A; Sultanoglu N; Goodbourn S; Randall RE; Kostrikis LG
Viruses; 2017 Jul; 9(7):. PubMed ID: 28703784
[TBL] [Abstract][Full Text] [Related]
19. Injectable Hydrogel Containing Cowpea Mosaic Virus Nanoparticles Prevents Colon Cancer Growth.
Nkanga CI; Steinmetz NF
ACS Biomater Sci Eng; 2022 Jun; 8(6):2518-2525. PubMed ID: 35522951
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
